Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Gina Gualano and Gilda Cuzzi.
Gina Gualano
Connection Strength
0.292
Gilda Cuzzi
  1. Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection. J Transl Med. 2021 06 26; 19(1):272.
    View in: PubMed
    Score: 0.060
  2. Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients. Int J Infect Dis. 2021 May; 106:338-347.
    View in: PubMed
    Score: 0.059
  3. Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2. Int J Infect Dis. 2021 Dec; 113 Suppl 1:S82-S87.
    View in: PubMed
    Score: 0.058
  4. In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy. J Infect. 2021 04; 82(4):58-66.
    View in: PubMed
    Score: 0.058
  5. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients. Clin Microbiol Infect. 2021 Feb; 27(2):286.e7-286.e13.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.